A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists.
about
Biologics in dermatology: an integrated reviewUstekinumab as an alternative treatment option for chronic pityriasis rubra pilarisIneffectiveness of tumor necrosis factor-α blockers and ustekinumab in a case of type IV pityriasis rubra pilaris.Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κBSuccessful treatment of type II pityriasis rubra pilaris with secukinumab.Management of refractory pityriasis rubra pilaris: challenges and solutions.Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.Pityriasis rubra pilaris: Algorithms for diagnosis and treatment.Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases.A case of juvenile pityriasis rubra pilaris type III successfully treated with etanercept.A Review on Pityriasis Rubra Pilaris.Immune response patterns in non-communicable inflammatory skin diseases.Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis.Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets.
P2860
Q27004638-8E84D1CD-71BD-4DEA-9319-E8436FBCC8D8Q35592460-ED748404-A69F-4E7E-B026-9B3516997E02Q35631234-2A7A3CCE-21D7-43B8-8A1A-F0E384B4ACEFQ35738571-C5577CB1-3AD8-4439-B79A-7BA5A131BA97Q42355182-94C13D64-E846-4A9B-BD26-AA4EBA8D62A7Q46027741-F1C8004F-7FD3-4ACB-B43C-84189E9097ACQ46788078-0BFE44B7-31C4-4DB5-989D-B6EC0F89FC85Q47299093-652D29BE-64D6-4DB3-832A-C6F276AD1BC0Q48109761-04D9ECB4-0485-49DC-9974-950AC44C2CF8Q48200778-91CBD646-4AB1-4975-B9C1-65476D7BA7D2Q48305451-F6CF5D38-B862-46F4-8291-98F41CC4839CQ50113782-73089F98-B681-4EEE-BE69-0BB262D0B243Q53975511-8F920C21-593C-4AF4-971E-A8CFF22C0B36Q55519145-33B87592-09C8-4E4B-85BC-23EA6F403D50
P2860
A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@ast
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@en
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@nl
type
label
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@ast
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@en
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@nl
prefLabel
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@ast
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@en
A systematic review of the lit ...... s type 1 with TNF-antagonists.
@nl
P2860
P50
P1476
A systematic review of the lit ...... is type 1 with TNF-antagonists
@en
P2093
C B Archer
W A D Griffiths
P2860
P304
P356
10.1111/J.1468-3083.2012.04456.X
P577
2012-02-10T00:00:00Z